← Back to headlines
What do we know about the new cholesterol pill, Lipfendra? Merck's new once-a-day drug gets FDA nod
The FDA has approved Merck's once-daily cholesterol pill Lipfendra (enlicitide), marking the first oral PCSK9 inhibitor.
18 Jul, 01:00 — 18 Jul, 01:00
Related Stories
Netherlands Records Hottest Summer on Record in 2026
15m ago
CIA Director Makes Unannounced Visit to Moscow to Warn Against NATO Attacks
18m ago
Russian Missile Strikes Hit Kyiv and Other Ukrainian Cities, Causing Casualties
19m ago
Five Drones Violate Moldovan Airspace During Russian Strike on Ukraine
23m ago